Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline adjunctive treatment for schizophrenia
IRCT20190914044769N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in schizophrenia comparing Pentoxifylline + standard treatment with Placebo + standard treatment (2 arms). Primary endpoints: Positive and negative symptoms of schizophrenia and Cognitive impairments. Started Jan 2020; status: completed.
02
Drugs
pentoxifylline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20190914044769N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190914044769N1.